1. Home
  2. ADUS vs HRMY Comparison

ADUS vs HRMY Comparison

Compare ADUS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$107.68

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.59

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
HRMY
Founded
1979
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
ADUS
HRMY
Price
$107.68
$37.59
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$138.73
$51.33
AVG Volume (30 Days)
156.1K
692.5K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
6.76
50.44
EPS
4.66
3.17
Revenue
$1,346,596,000.00
$825,944,000.00
Revenue This Year
$25.50
$23.11
Revenue Next Year
$7.11
$16.15
P/E Ratio
$23.31
$11.88
Revenue Growth
18.77
21.13
52 Week Low
$88.96
$25.52
52 Week High
$136.72
$40.93

Technical Indicators

Market Signals
Indicator
ADUS
HRMY
Relative Strength Index (RSI) 34.08 53.55
Support Level $110.12 $37.12
Resistance Level $111.57 $39.60
Average True Range (ATR) 2.22 1.08
MACD -0.56 -0.40
Stochastic Oscillator 1.81 15.84

Price Performance

Historical Comparison
ADUS
HRMY

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: